Sentegen Biotechnology, Turkey's leading synthetic biology company, is dedicated to creating innovative solutions in English. Founded in 2010 with the support of the Ministry of Science, Industry and Technology, Sentegen operates at the forefront of genetic engineering and bioengineering. The company's synthetic biology laboratory, sentebiolab, located in Bilkent, Cyberpark, specializes in producing genetic-based biological and commercial synthetic biology solutions for a diverse range of industries. Sentegen's commitment to high-quality services for researchers in its laboratory not only accelerates research but also positions the company as a key player in the Biotechnology, Deep Tech, and Life Sciences industries. With a track record of success and the potential for future growth, Sentegen presents an attractive investment opportunity for venture capitalists seeking to tap into the promising synthetic biology sector.
There is no investment information
No recent news or press coverage available for Sentegen Biotech.